NEW YORK (360Dx) – Becton Dickinson said today that it has received 510(k) clearance from the US Food and Drug Administration for an automated flow cytometer system with a Leucocount reagent assay used in residual white blood cell enumeration.

The BD FACSVia system enables identifying and counting of rWBCs in leucoreduced blood products when it's used with the BD Leucocount kit and BD Trucount tubes, the firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.